Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2006-12-12 Investor Presentation
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Investor Presentation Classification · 95% confidence The document is a press release announcing that the CEO of XTL Biopharmaceuticals will present at the NYSSA 10th Annual Biotech/Specialty Pharma Industry Conference. It includes details about the presentation date, time, and webcast information. There is no financial data, no report attached or referenced as being published, and no regulatory filing or certification. The content is clearly an announcement of an investor presentation event rather than the presentation materials themselves or a financial report. Therefore, the most appropriate classification is Investor Presentation (IP). The document length is short and it is an announcement of a presentation, fitting the IP category rather than a report or announcement of a report publication.
2006-12-12 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 98% confidence The document is a short regulatory filing (1617 characters) from XTL BIOPHARMACEUTICALS LTD, dated 12/12/2006. It explicitly states under 'Other Report or Announcement' that it is attaching a report titled '*Presentation of the CEO at NYSSA Conference*' with the file name '*XTLNYSSAPressRelease1206_isa.pdf*'. According to Rule 2 ('MENU VS MEAL'), when a document is short and announces the publication of another report (like a presentation), it should be classified as a Report Publication Announcement (RPA). The content is an announcement about a CEO presentation, which fits the RPA definition better than Investor Presentation (IP) itself, as this document is merely the cover/announcement.
2006-12-12 English
Investor Presentation 2006
Investor Presentation Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It announces corporate presentations at two healthcare conferences, including details about the CEO's scheduled presentations and webcast links. The document does not contain financial statements or detailed financial analysis, nor does it present earnings results or management discussion. It is primarily an announcement of investor presentations. According to the filing definitions, announcements of presentations for investors focusing on financials, strategy, and market position are classified as Investor Presentation (IP). The document length is under 5,000 characters but contains substantive information about the presentations themselves, not just a notice of report availability, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is Investor Presentation (IP).
2006-11-08 English
Other Report or Announcement
Investor Presentation Classification · 90% confidence The document is a press release announcing that the CEO of XTL Biopharmaceuticals will present at two healthcare conferences on a specific date. It includes details about the event times, locations, and webcast availability. There is no financial data, no detailed investor presentation content, no report attached or referenced as published, and no regulatory filing or certification. The document is essentially an announcement of upcoming corporate presentations to investors and analysts. Therefore, it fits the category of Investor Presentation (IP) announcements, as it focuses on informing about presentations related to financial and strategic information, even though the full presentation content is not included here. Given the nature and content, the classification is Investor Presentation (IP) with high confidence.
2006-11-06 Hebrew (modern)
Other Report or Announcement
Regulatory Filings Classification · 90% confidence The document is very short (1605 characters) and explicitly states that an attached report is available: "Attached hereto is a report on *Participation in Conferences*" followed by a filename. This fits the 'MENU VS MEAL' rule, indicating it is an announcement about a report rather than the report itself. The subject matter is 'Participation in Conferences'. Among the provided codes, 'IP' (Investor Presentation) or 'IR' (Interim Report) might seem related to presentations, but 'Participation in Conferences' is a specific type of event disclosure. Since there is no specific code for 'Conference Participation Announcement', and it is an announcement of material being made public, the most appropriate general category for investor-related materials that aren't formal financial reports (10-K, IR) or proxy statements (DEF 14A) is often 'IP' (Investor Presentation) if the material is a presentation, or the fallback 'RNS' if it's a general regulatory announcement. Given the context of presenting at a conference, 'IP' (Investor Presentation) is a strong candidate for the *content* type, but the *action* is an announcement. However, looking closely at the definitions, 'IP' is for 'Investor Presentation'. Since this is an announcement of participation in a conference, which often involves presenting investor materials, and it's not a standard financial report, I will check if 'RNS' (Regulatory Filings - general fallback) is better. Since the document explicitly mentions 'Participation in Conferences' and attaches a PDF, this is a specific type of investor communication. If we must choose from the list, and it's not a formal financial report, 'IP' covers investor-facing materials. However, the most accurate classification for a brief announcement stating a document is attached, which doesn't fit a specific financial report code, is often 'RNS' (Regulatory Filings) or 'RPA' (Report Publication Announcement). Since 'Participation in Conferences' is a specific event, and the document is an announcement of that event's material, 'RPA' is plausible if we interpret 'report' broadly. Given the content is about presenting information to investors (conference participation), 'IP' (Investor Presentation) is the closest thematic fit for the attached material, even though this document is the announcement wrapper. Given the ambiguity and the nature of the filing (announcing material related to investor engagement), I will lean towards the most specific category related to investor materials that isn't a formal financial statement, which is 'IP', assuming the attached PDF is an investor presentation. If it were purely administrative, RNS would be better. I will re-evaluate based on the 'MENU VS MEAL' rule: it's an announcement wrapper. Therefore, RPA or RNS. Since 'Participation in Conferences' is a specific event disclosure, RNS (General Regulatory Announcement/Fallback) is safer than RPA (which usually announces the release of a formal report like 10-K or IR). I will use RNS as the fallback for this specific type of announcement wrapper.
2006-11-06 English
Declaration of Voting Results & Voting Rights Announcements 2006
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It contains announcements about the CEO's upcoming presentation at a healthcare conference and the results of an adjourned Annual General Meeting where all resolutions were approved. The document does not contain detailed financial statements or substantive financial data, nor is it a transcript or detailed report. It primarily announces the AGM voting results and a presentation event. Given the mention of AGM resolutions being approved, the document fits best as a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4634 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the classification is DVA with high confidence.
2006-11-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.